(Q54668950)
Statements
SYK carries no activating point mutations in patients with chronic lymphocytic leukaemia (CLL). (English)
Hartmut Döhner
1 reference
Thorsten Zenz
1 reference
Stephan Stilgenbauer
Angela Philippen
Susanne Diener
26 May 2010
150
5
633-636